Enabling data-driven diagnosis, patient insights & therapeutic development for brain diseases & disorders across the lifespan.
There are millions of brain MRIs/CTs done yearly. The scans are read manually and only analysed qualitatively, yet 99% of the data behind them is non-actionable and sitting dormant.
Global trends are set to worsen this gap in the coming years as an ageing population will increase the need for clinical radiological assessment while the workforce of people able to read them is set to decline.
There are millions of brain MRIs/CTs done yearly. The scans are read manually and only analysed qualitatively, yet 99% of the data behind them is non-actionable and sitting dormant.
Global trends are set to worsen this gap in the coming years as an ageing population will increase the need for clinical radiological assessment while the workforce of people able to read them is set to decline.
Radiologists rely on a small fraction of the data to make clinical decisions
Screening & diagnosis
Standards & automation
Triaging & prioritization
The Centile Bio team comprises global leaders with exceptional complementary expertise, and over a decade of established collaborations in all relevant areas of lifespan neuroimaging, neuroinformatics, clinical applications, commercialization.
This and translational foundation provides unprecedented opportunity to revolutionize the clinical care and management of brain disorders through the development of quantitative biomarkers and diagnostics.
The Centile Bio team comprises global leaders with exceptional complementary expertise, and over a decade of established collaborations in all relevant areas of lifespan neuroimaging, neuroinformatics, clinical applications, commercialization.
This and translational foundation provides unprecedented opportunity to revolutionize the clinical care and management of brain disorders through the development of quantitative biomarkers and diagnostics.
